Evidence-Based Treatments and Prescription Variability after Acute Myocardial Infarction

被引：0
|
作者：
Marco Bobbio
Massimo Imazio
Massimo Tidu
机构：
[1] University Cardiology Department,
[2] Department of Medicine,undefined
[3] Molinette Hospital,undefined
[4] University of Turin,undefined
来源：
Clinical Drug Investigation | 1999年 / 17卷
关键词：
Aspirin; Adis International Limited; Acute Myocardial Infarction; Acute Myocardial Infarction; Calcium Antagonist;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Objective: Since there is growing interest in the prescribing of different drugs in various clinical settings, the aim of the study was to verify whether drug prescribing after acute myocardial infarction can be explained on the basis of evidence-based treatment.
引用
收藏
页码：241 / 250
页数：9
相关论文
共 50 条
  • [31] Underuse of evidence-based medicine and outcome of acute myocardial infarction patients with renal failure
    Tessone, A
    Barbash, IM
    Gottlieb, S
    Battler, A
    Hasin, Y
    Boyko, V
    Porat, A
    Behar, S
    Leor, J
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (05) : 316A - 317A
  • [32] EFFECTS OF "EVIDENCE-BASED" THERAPY IN SECONDARY PREVENTION FOR THE ACUTE MYOCARDIAL INFARCTION: METHODOLOGICAL CHALLENGES
    Di Martino, M.
    Kirchmayer, U.
    Bauleo, L.
    Agabiti, N.
    Fusco, D.
    Davoli, M.
    EPIDEMIOLOGIA & PREVENZIONE, 2011, 35 (5-6): : 51 - 51
  • [33] Implementation of Evidence-Based Therapies for Myocardial Infarction and Survival
    Mukherjee, Debabrata
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2011, 305 (16): : 1710 - 1711
  • [34] Disparities in the treatment of acute myocardial infarction: Underutilization of evidence-based therapies for patients with non-ST-segment myocardial infarction
    Roe, MT
    Parsons, L
    Pollack, C
    Canto, JG
    Barron, HV
    Every, N
    Rogers, W
    Peterson, ED
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (06) : 540A - 541A
  • [35] Effect of evidence-based nursing combined with exercise rehabilitation in patients with acute myocardial infarction after percutaneous coronary intervention
    Liu, Xiaolan
    Zou, Yan
    Huang, Donghua
    Lu, Honghua
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2022, 14 (10): : 7424 - 7433
  • [36] Contemporary use of evidence-based therapies in high risk groups after myocardial infarction
    O'Neill, BJ
    Bata, IR
    Johnstone, DE
    Flowerdew, G
    Cox, JL
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 35 (02) : 346A - 347A
  • [37] How Can We Increase the Utilization of Evidence-Based Medication After Myocardial Infarction?
    Cavender, Matthew A.
    Smith, Sidney C.
    JAMA NETWORK OPEN, 2024, 7 (11)
  • [38] Evidence-based, cost-effective risk stratification and management after myocardial infarction
    Deedwania, PC
    Amsterdam, EA
    Vagelos, RH
    Gregoratos, G
    Kappagoda, T
    Viejo, A
    Caso, R
    Chatterjee, K
    Dennish, G
    Elkayam, U
    Fonarow, G
    Golden, P
    Goldschlager, N
    Kane, JP
    Karliner, JS
    Kloner, RM
    Shabatei, R
    Berman, D
    Superko, B
    ARCHIVES OF INTERNAL MEDICINE, 1997, 157 (03) : 273 - 280
  • [39] Evidence-based oral antiplatelet therapy among hospitalized Chinese patients with acute myocardial infarction: results from the Chinese acute myocardial infarction registry
    Tang, Xiaofang
    Liu, Lifu
    Yang, Jingang
    Gao, Zhan
    Zhao, Xueyan
    Qiao, Shubin
    Gao, Runlin
    Wang, Zhifang
    Yuan, Jinqing
    Yang, Yuejin
    BMC CARDIOVASCULAR DISORDERS, 2021, 21 (01)
  • [40] Evidence-based oral antiplatelet therapy among hospitalized Chinese patients with acute myocardial infarction: results from the Chinese acute myocardial infarction registry
    Xiaofang Tang
    Lifu Liu
    Jingang Yang
    Zhan Gao
    Xueyan Zhao
    Shubin Qiao
    Runlin Gao
    Zhifang Wang
    Jinqing Yuan
    Yuejin Yang
    BMC Cardiovascular Disorders, 21
12345